EP Patent

EP0707478B1 — Improved nicotine lozenge

Assigned to McNeil AB · Expires 2011-07-06 · 15y expired

What this patent protects

A method for smoking cessation therapy is described that is utilizing an improved nicotine lozenge to satisfy transient craving. The lozenge contains nicotine, a non-nutritive sweetener and an absorbent excipient.

USPTO Abstract

A method for smoking cessation therapy is described that is utilizing an improved nicotine lozenge to satisfy transient craving. The lozenge contains nicotine, a non-nutritive sweetener and an absorbent excipient.

Drugs covered by this patent

Patent Metadata

Patent number
EP0707478B1
Jurisdiction
EP
Classification
—
Expires
2011-07-06
Drug substance claim
No
Drug product claim
No
Assignee
McNeil AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.